Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of the process of directing proteins towards a membrane, usually using signals contained within the protein. [GOC:tb]
Protein targeting to membranes is a complex process that ensures proteins are delivered to their correct destinations within the cell. This precise delivery is essential for maintaining cellular function and is regulated by a sophisticated interplay of signals and mechanisms.
**1. Signal Recognition:** The journey begins with the synthesis of proteins on ribosomes. Many proteins destined for membranes contain specific signal sequences, short stretches of amino acids that act like "zip codes," directing them to their target.
**2. Signal Recognition Particle (SRP):** In the cytoplasm, the SRP, a protein-RNA complex, recognizes these signal sequences as they emerge from the ribosome. The SRP then binds to the ribosome, halting translation temporarily.
**3. SRP Receptor:** The SRP-ribosome complex moves to the endoplasmic reticulum (ER), a network of interconnected membranes that serves as a central hub for protein sorting. The SRP binds to the SRP receptor, a protein embedded in the ER membrane.
**4. Translocation Channel:** Once the SRP-ribosome complex docks at the ER, the ribosome binds to a protein translocator, a channel in the ER membrane. The signal sequence is then threaded through this channel.
**5. Protein Translocation:** As the protein is synthesized, it is pushed through the translocator channel. The signal sequence acts as a guide, leading the growing polypeptide chain into the ER lumen (the space between the ER membrane).
**6. Signal Peptidase:** Once the entire protein has entered the ER lumen, the signal sequence is cleaved off by an enzyme called signal peptidase.
**7. Folding and Modification:** Inside the ER, proteins undergo folding, modification, and quality control. They may acquire additional modifications, such as glycosylation (addition of sugars), and are subjected to chaperones that assist in proper folding.
**8. Sorting and Delivery:** From the ER, proteins are sorted and transported to their final destinations. Some remain in the ER, while others are sent to the Golgi apparatus, lysosomes, or the plasma membrane.
**9. Targeting Signals:** Specific targeting signals within the protein determine its final destination. For example, a signal sequence for the Golgi apparatus directs proteins to that organelle.
**10. Vesicle Transport:** Proteins are packaged into membrane-bound vesicles and transported along the secretory pathway, moving from the ER to the Golgi and then to their final destinations.
**11. Membrane Insertion:** Some proteins destined for membranes remain embedded in the membrane during translocation. These transmembrane proteins contain hydrophobic regions that anchor them within the lipid bilayer.
**12. Protein Trafficking:** The movement of proteins within the cell is tightly regulated and involves a complex network of proteins, including motor proteins, adaptors, and vesicle-associated proteins (V-SNAREs and T-SNAREs).
**13. Quality Control:** At each step, the cell has mechanisms for quality control to ensure that misfolded or improperly targeted proteins are identified and degraded.
This intricate process of protein targeting to membranes is essential for cell function and is essential for maintaining cellular homeostasis. It underscores the complexity and efficiency of cellular processes.**
"
Protein | Definition | Taxonomy |
---|---|---|
Excitatory amino acid transporter 3 | An excitatory amino acid transporter 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P43005] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. | non-proteinogenic alpha-amino acid | |
cysteine | cysteine; cysteine zwitterion; L-alpha-amino acid; proteinogenic amino acid; serine family amino acid | EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; flour treatment agent; human metabolite | |
aspartic acid | aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. L-aspartic acid : The L-enantiomer of aspartic acid. | aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; mouse metabolite; neurotransmitter |
glutamic acid | glutamic acid : An alpha-amino acid that is glutaric acid bearing a single amino substituent at position 2. Glutamic Acid: A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
sym 2081 | |||
dihydrokainate | dicarboxylic acid | ||
serine o-sulfate | L-serine O-sulfate : A non-proteinogenic L-alpha-amino acid that is the O-sulfo derivative of L-serine. serine O-sulfate: RN given refers to (L)-isomer | L-serine derivative; non-proteinogenic L-alpha-amino acid; O-sulfoamino acid | |
hinokinin | hinokinin : A lignan that is dihydrofuran-2(3H)-one (gamma-butyrolactone) substituted by a 3,4-methylenedioxybenzyl group at positions 3 and 4 (the 3R,4R-diastereoisomer). hinokinin: suppresses expression of both HBsAg and HBeAg | benzodioxoles; gamma-lactone; lignan | trypanocidal drug |
3-hydroxyaspartic acid, (threo-l)-isomer | (3S)-3-hydroxy-L-aspartic acid : The (3S)-diastereomer of 3-hydroxy-L-aspartic acid. | 3-hydroxy-L-aspartic acid | metabolite |
2-amino-3-phenylmethoxybutanedioic acid | aspartic acid derivative | ||
dl-threo-beta-benzyloxyaspartate | |||
l-beta-threo-benzyl-aspartate | L-beta-threo-benzyl-aspartate: structure in first source | ||
ucph 101 | 2-amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile: structure in first source |